Histopathology of experimental invasive pulmonary aspergillosis in rats: Pathological comparison of pulmonary lesions induced by specific virulent factor deficient mutants

Microbial Pathogenesis

Volumn 27, Issue 3, 1999, Pages 123-131

  Shibuya, Kazutoshi ^a   Takaoka, Masayoshi ^b   Uchida, Katsuhisa ^c   Wakayama, Megumi ^a   Yamaguchi, Hideyo ^c   Takahashi, Kei ^a   Paris, Sophie ^d   Latge, Jean Paul ^d   Naoe, Shiro ^a  

^a TOHO UNIVERSITY OHASHI MEDICAL CENTER   (Japan)

^b ICAM Co Ltd   (Japan)

^c TEIKYO UNIVERSITY   (Japan)

^d INSTITUT PASTEUR   (France)

Author keywords

Aspergillus fumigatus; Experimental model; Invasive pulmonary aspergillosis; Pathology; Protease; Rodlet layer

Indexed keywords

AMPICILLIN; CYCLOPHOSPHAMIDE; GALACTOMANNAN; IMMUNOSUPPRESSIVE AGENT; PREDNISOLONE; PROTEINASE; VIRULENCE FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASPERGILLUS FUMIGATUS; CONTROLLED STUDY; EXPERIMENTAL INFECTION; FEMALE; FUNGUS MUTANT; HISTOPATHOLOGY; INFLAMMATION; LUNG ASPERGILLOSIS; MACROPHAGE; MALE; MORTALITY; MOUSE; NEUTROPHIL; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALIA; ASPERGILLUS FUMIGATUS; FUNGI; RODENTIA;

EID: 0032861347     PISSN: 08824010     EISSN: None     Source Type: Journal    
DOI: 10.1006/mpat.1999.0288     Document Type: Article

References (19)

1. Gefter WB. The spectrum of pulmonary aspergillosis. J Thorac Imaging. 7:1992;56-74.
2. Guiot HFL, Fibbe WE, van't Wout JW. Risk factors for fungal infection in patients with malignant hematologic disorders. Implications for empirical therapy and prophylaxis. Clin Infect Dis. 18:1994;525-532.
3. Binder RE, Faling LJ, Pugatch RD, Mahasaen C, Snider GL. Chronic necrotizing pulmonary aspergillosis: A discrete clinical entire. Medicine. 61:1982;109-124.
4. Shibuya K, Ando T, Wakayama M, Takaoka M, Uchida K, Naoe S. Pathological spectrum of invasive pulmonary aspergillosis: study of pulmonary lesions of 54 autopsies and the relationship between neutrophilic response and histologic features of lesions in experimental aspergillosis. Jpn J Med Mycol. 38:1997;175-181.
5. Jaton-Ogay K, Paris S, Huerre M. Cloning and disruption of the gene encoding an extracellular metalloprotease of Aspergillus fumigatus. Mol Microbiol. 14:1994;917-928.
6. Thau N, Monod M, Crestani B. Rodletless mutants of Aspergillus fumigatus. Infect Immun. 62:1994;4380-4388.
7. Kwon-Chung KJ, Bennett JE. Medical Mycology. 1st edn. Philadelphia: Lea & Febiger. 1992;201-247.
8. Smith JM, Tang CM, Van Noorden S, Holden DW. Virulence of Aspergillus fumigatus double mutants lacking restriction and an alkaline protease in a low-dose model of invasive pulmonary aspergillosis. Infect Immun. 62:1994;5247-5254.
9. Miyaji M, Yamaguchi H. Animal models in medical mycology. 1st edn. Boca Raton, Florida: CRC Press. 1987;103-111.
10. Jensen HE, Aalbaek B, Hau J, Latge JP. Detection of galactomannan and complement activation in the pregnant mouse during experimental systemic aspergillosis. APMIS. 104:1996;926-932.
11. Tang CM, Cohen J, Krausz T, Van Noorden S, Holden DW. The alkaline protease of Aspergillus fumigatus is not a virulence determinant in two murine models of invasive pulmonary aspergillosis. Infect Immun. 61:1993;1650-1656.
12. Mellado E, Specht CA, Robbins PW, Holden DW. Cloning and characterization of chsD, a chitin synthase-like gene of Aspergillus fumigatus. FEMS Microbiol Lett. 143:1996;69-76.
13. Mondon P, De Champs C, Donadille A, Ambroise-Thomas P, Grillot R. Variation in virulence of Aspergillus fumigatus strains in a murine model of invasive pulmonary aspergillosis. J Med Microbiol. 45:1996;186-191.
14. Frosco MB, Chase T, Macmillan JD. The effect of elastase-specific monoclonal and polyclonal antibodies on the virulence of Aspergillus fumigatus in immunocompromised mice. Mycopathologia. 125:1994;65-76.
15. Muhlschlegal F, Fonzi W, Hoyer L. Molecular mechanisms of virulence in fungus-host interactions for Aspergillus fumigatus and Candida albicans. Med Mycol. 36 (Suppl 1):1998;238-248.
16. Dixon DM, Polak A, Walsh J. Fungus dose-dependent primary pulmonary aspergillosis in immunosuppressed mice. Infect Immun. 75:1989;1452-1456.
17. Eisenstein DJ, Biddinger PW, Rhodes JC. Experimental murine invasive pulmonary aspergillosis. Am J Clin Pathol. 93:1990;510-515.
18. Cash HA, Woods DE, McCullough B, Johanson WG, Bass JA. A rat model of chronic respiratory infection with Pseudomonas aeruginosa. Am Rev Respir Dis. 119:1979;453-459.
19. Stynen D, Sarfati J, Goris A. Rat monoclonal antibody against Aspergillus galactomannan. Infect Immun. 60:1992;2237-2245.